An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012690 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Suélen Fernandes Silva und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden. Hauptthemen laut MEDLINE: Plasmodium vivax, Saccharomyces cerevisiae, Antimalarials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Fund, Swedish Foundation for International Cooperation in Research and Higher Education.
Abstract (Originalsprache)
The enzyme deoxyhypusine synthase (DHS) catalyzes the first step in the post-translational modification of the eukaryotic translation factor 5A (eIF5A). This is the only protein known to contain the amino acid hypusine, which results from this modification. Both eIF5A and DHS are essential for cell viability in eukaryotes, and inhibiting DHS is a promising strategy to develop new therapeutic alternatives. DHS proteins from many are sufficiently different from their human orthologs for selective targeting against infectious diseases; however, no DHS inhibitor selective for parasite orthologs has previously been reported. Here, we established a yeast surrogate genetics platform to identify inhibitors of DHS from Plasmodium vivax , one of the major causative agents of malaria. We constructed genetically modified Saccharomyces cerevisiae strains expressing DHS genes from Homo sapiens (HsDHS) or P . vivax (PvDHS) in place of the endogenous DHS gene from S . cerevisiae . Compared with a HsDHS complemented strain with a different genetic background that we previously generated, this new strain background was ~60-fold more sensitive to an inhibitor of human DHS. Initially, a virtual screen using the ChEMBL-NTD database was performed. Candidate ligands were tested in growth assays using the newly generated yeast strains expressing heterologous DHS genes. Among these, two showed promise by preferentially reducing the growth of the PvDHS-expressing strain. Further, in a robotized assay, we screened 400 compounds from the Pathogen Box library using the same S . cerevisiae strains, and one compound preferentially reduced the growth of the PvDHS-expressing yeast strain. Western blot revealed that these compounds significantly reduced eIF5A hypusination in yeast. The compounds showed antiplasmodial activity in the asexual erythrocyte stage; EC 50 in high nM to low μM range, and low cytotoxicity. Our study demonstrates that this yeast-based platform is suitable for identifying and verifying candidate small molecule DHS inhibitors, selective for the parasite over the human ortholog.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
- Chemistry Institute, São Paulo State University - UNESP, Araraquara, São Paulo, Brazil.
- Center for Medicinal Chemistry - CQMED, Center for Molecular Biology and Genetic Engineering - CBMEG, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
- School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
- Department of Life Sciences, Chalmers, Göteborg, Sweden.
- Laboratory of Tropical Diseases, Institute of Biology, Universidade Estadual de Campinas - UNICAMP, Campinas, São Paulo, Brazil.
ORCID-Profile: Per Sunnerhagen
Förderung
- Swedish Research Council
- Swedish Cancer Fund
- Swedish Foundation for International Cooperation in Research and Higher Education
- FAPESP
- CAPES
- INCT
Zitieren
APA
Fernandes Silva, S., Hollunder Klippel, A., Sigurdardóttir, S., Mahdizadeh, S. J., Tiukova, I., Bourgard, C., Salazar-Alvarez, L. C., do Amaral Prado, H. M., de Araujo, R. V., Costa, F. T. M., Bilsland, E., King, R. D., Brauer Massirer, K., Eriksson, L. A., Bengtson, M. H., Zanelli, C. F., & Sunnerhagen, P. (2024). An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012690
Vancouver
Fernandes Silva S, Hollunder Klippel A, Sigurdardóttir S, Mahdizadeh SJ, Tiukova I, Bourgard C, et al. An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012690
BibTeX
@article{FernandesSilva2024,
author = {Fernandes Silva, Suélen and Hollunder Klippel, Angélica and Sigurdardóttir, Sunniva and Mahdizadeh, Sayyed Jalil and Tiukova, Ievgeniia and Bourgard, Catarina and Salazar-Alvarez, Luis Carlos and do Amaral Prado, Heloísa Monteiro and de Araujo, Renan Vinicius and Costa, Fabio Trindade Maranhão and Bilsland, Elizabeth and King, Ross D and Brauer Massirer, Katlin and Eriksson, Leif A and Bengtson, Mário Henrique and Zanelli, Cleslei Fernando and Sunnerhagen, Per},
title = {An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012690}
}
EUVIMED